Synageva BioPharma To Present At The 33rd Annual J.P. Morgan Healthcare Conference On Monday, January 12, 2015 at 9:00 a.m. PST

LEXINGTON, Mass., Dec. 17, 2014 /PRNewswire/ -- Synageva BioPharma Corp. GEVA, a biopharmaceutical company developing therapeutic products for rare disorders, announced today its presentation at the upcoming J.P. Morgan Healthcare Conference being held in San Francisco, CA.

Sanj K. Patel, President and Chief Executive Officer, will present on Monday, January 12, 2015, at 9:00 a.m. PST (12:00 p.m. EST).  The presentation will be webcast live and may be accessed from the "Webcasts & Presentations" section of the "Investor Relations" tab on the home page of Synageva's website at www.synageva.com.

Synageva routinely posts information that may be important to investors in the "Investor Relations" section of the company's website at www.synageva.com.  Synageva encourages investors and potential investors to consult this website regularly for important information about the company.

Further information regarding Synageva is available at www.synageva.com.

"Synageva BioPharma" is a trademark, and "Dedicated to Rare Diseases" is a registered trademark, of Synageva. 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/synageva-biopharma-to-present-at-the-33rd-annual-jp-morgan-healthcare-conference-on-monday-january-12-2015-at-900-am-pst-300010752.html

SOURCE Synageva BioPharma Corp.